SecBot SecBot
SECBOTREPLAY Home › Report › DAWN

DAWN · Nasdaq has filed Form 25 to delist Day One Biopharmaceuticals (DAWN)…

Day One Biopharmaceuticals, Inc. · 25-NSE filed Apr 23, 2026 at 09:14 ET

At the news

NEUTRALIMPACT 9/10

25-NSE filed Apr 23, 2026 at 09:14 ET

Nasdaq has filed Form 25 to delist Day One Biopharmaceuticals (DAWN) common stock, effective immediately, following the company's acquisition by Servier Pharmaceuticals. This is a procedural step confirming the completion of the take-private transaction.

  • Form 25-NSE filed by Nasdaq to delist DAWN common stock
  • Effective date of delisting is 2026-04-23
  • Follows the previously announced acquisition of Day One by Servier Pharmaceuticals
  • Merger closed after Servier secured 85.34% of shares via tender offer

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access